[{"AccountsPayableCurrent_0_Q3_USD":32755000.0,"OperatingIncomeLoss_3_Q3_USD":-84719000.0,"OperatingLeaseCost_1_Q3_USD":1333000.0,"OperatingLeaseCost_3_Q3_USD":3901000.0,"OperatingLeaseLiability_0_Q3_USD":20639000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":4360000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":16279000.0,"OperatingLeasePayments_1_Q3_USD":1373000.0,"OperatingLeasePayments_3_Q3_USD":3880000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":18196000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.07,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":4776000.0,"OtherAssetsNoncurrent_0_Q3_USD":4456000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-8000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-127000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-401000.0,"OperatingIncomeLoss_1_Q3_USD":-46444000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-651000.0,"OperatingExpenses_3_Q3_USD":281629000.0,"NumberOfOperatingSegments_3_Q3_Business":1.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":1373000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":3487000.0,"Liabilities_0_Q3_USD":263226000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":582428000.0,"LiabilitiesCurrent_0_Q3_USD":74847000.0,"LitigationSettlementExpense_1_Q3_USD":20000000.0,"LitigationSettlementExpense_3_Q3_USD":20000000.0,"LongTermDebtNoncurrent_0_Q3_USD":148805000.0,"LossContingencyAccrualAtCarryingValue_0_Q3_USD":20000000.0,"MoneyMarketFundsAtCarryingValue_0_Q3_USD":23300000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-172657000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":235947000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-26722000.0,"NetIncomeLoss_1_Q3_USD":-50075000.0,"NetIncomeLoss_3_Q3_USD":-101226000.0,"OperatingExpenses_1_Q3_USD":111074000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-409000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-778000.0,"OtherLiabilitiesCurrent_0_Q3_USD":4459000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":34956000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":606000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-594059000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":93205000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":284145000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":79521000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":226673000.0,"ShareBasedCompensation_3_Q3_USD":32908000.0,"StandardProductWarrantyAccrualCurrent_0_Q3_USD":544000.0,"StandardProductWarrantyAccrualPayments_1_Q3_USD":900000.0,"StandardProductWarrantyAccrualPayments_3_Q3_USD":2054000.0,"StandardProductWarrantyAccrualWarrantiesIssued_1_Q3_USD":622000.0,"StandardProductWarrantyAccrualWarrantiesIssued_3_Q3_USD":1899000.0,"StockholdersEquity_0_Q3_USD":319202000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":51000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":11553000.0,"RepaymentsOfConvertibleDebt_3_Q3_USD":172500000.0,"ProvisionForDoubtfulAccounts_3_Q3_USD":-1222000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":20303000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":23295000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":30000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-515000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":6491000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":354614000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":10610000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":5892000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockValue_0_Q3_USD":null,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":7036000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":6334000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":601171000.0,"ProfitLoss_3_Q3_USD":-101226000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":41546000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":34878443.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":6069000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":5618000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q3_USD":58267000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q3_USD":279648000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":279662000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":337929000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":295684000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":482000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":80885000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":81491000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":36288000.0,"CashUninsuredAmount_0_Q3_USD":8500000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommonStockSharesAuthorized_0_Q3_shares":290000000.0,"CommonStockSharesIssued_0_Q3_shares":34898631.0,"CommonStockSharesOutstanding_0_Q3_shares":34898631.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q3_USD":58281000.0,"CommonStockValue_0_Q3_USD":35000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":337929000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":28000.0,"AccountsReceivableNetCurrent_0_Q3_USD":63460000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-1008000.0,"AccruedIncomeTaxesCurrent_0_Q3_USD":471000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":37633000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":5446000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":21243000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-180000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":913406000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q3_USD":1375000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":12634000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":1706000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":10759000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":7170026.0,"Assets_0_Q3_USD":582428000.0,"AssetsCurrent_0_Q3_USD":538867000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":28000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-50484000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-102004000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":28575000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-14983000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-4718000.0,"IncreaseDecreaseInInventories_3_Q3_USD":23236000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":16684000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":416000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2878000.0,"InterestExpense_1_Q3_USD":3688000.0,"InterestExpense_3_Q3_USD":15939000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":49175000.0,"InventoryNet_0_Q3_USD":91802000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":42627000.0,"InventoryWriteDown_3_Q3_USD":3707000.0,"InvestmentIncomeInterest_1_Q3_USD":99000.0,"InvestmentIncomeInterest_3_Q3_USD":559000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":24126000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":17896000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":612000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":72000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-100614000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":87235000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_1_Q3_USD":200000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_3_Q3_USD":2800000.0,"DepreciationDepletionAndAmortization_1_Q3_USD":1220000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":3470000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-1.44,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.91,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":2792000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_Q3_USD":-280000.0,"ForeignCurrencyTransactionGainLossRealized_1_Q3_USD":787000.0,"ForeignCurrencyTransactionGainLossRealized_3_Q3_USD":2385000.0,"ForeignCurrencyTransactionGainLossUnrealized_1_Q3_USD":-745000.0,"ForeignCurrencyTransactionGainLossUnrealized_3_Q3_USD":-2861000.0,"GrossProfit_1_Q3_USD":64630000.0,"GrossProfit_3_Q3_USD":196910000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-50003000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":26049000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":34774423.0,"Ticker":"NVRO","CIK":"1444380","name":"NEVRO CORP","OfficialName":"Nevro Corp. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2648227724.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20211108"}]